Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANG1005 in Recurrent High-Grade Glioma
NCT01967810Phase 2Completed
- Sponsor
- Angiochem Inc.
- Start
- Oct 2013
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel trevatide in high-grade glioma (HGG), sponsored by Angiochem Inc.. Started Oct 2013; status: completed.
02
Drugs
paclitaxel trevatide
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT01967810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967810.